Razei Bar industries Ltd. Report issue

For profit Phase 4
Founded: Jerusalem Israel (1996)
Status: Defunct (2016)

Organization Overview

First Clinical Trial
2006
NCT00375115
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

european elderberry (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Influenza, Human (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1